FDA.reportPublic FDA data

dapsone 0.05 MG/MG Topical Gel [Aczone]

RxCUI
701858
RxNorm name
dapsone 0.05 MG/MG Topical Gel [Aczone]
Display name
dapsone 0.05 MG/MG Topical Gel [Aczone]
Full name
dapsone 0.05 MG/MG Topical Gel [Aczone]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:39:17

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ACZONEDAPSONEAllergan, Inc.b7d605cf-bf84-461b-939b-1f773a4cba652018-05-28Warnings, Adverse reactionsExact identifier
rxcui: 701858

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b7d605cf-bf84-461b-939b-1f773a4cba65Aczone 5 % Topical Gel [PSN] · dapsone 0.05 MG/MG Topical Gel [Aczone] [SBD] · Aczone 0.05 MG/MG Topical Gel [SY] · Aczone 5 % Topical Gel [SY]416These highlights do not include all the information needed to use ACZONE ® Gel, 5% safely and effectively. See full prescribing information for ACZONE ® Gel, 5%. ACZONE ® (dapsone) Gel, 5%, for topical use Initial U.S. Approval: 195520180528